drugset / Trial / NCT00775762

Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events

NCT00775762

Phase 3 Unknown 213 enrolled Catholic University of the Sacred Heart
RandomizedParallel-groupOpen-labelBasic science

Summary

This is a monocentric, randomized, opened study to assess the anti-inflammatory and anti-platelet effect of Clopidogrel and aspirin versus aspirin or clopidogrel alone in patients with symptomatic polyvascular disease and with multiple recurrent cardiovascular events.

Timeline

Start
2008-11
Primary completion
2009-01
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 75 mg
Comparator Aspirin Small molecule 100 mg
Comparator Clopidogrel Small molecule 75 mg

Indications